[Hyperuricemia]
- PMID: 16498814
[Hyperuricemia]
Abstract
The association of elevated serum uric acid (hyperuricemia, gout) with the presence of classical coronary risk factors and coronary artery disease or myocardial infarction has been analysed in many epidemiological studies. In this paper the urid acid metabolism, the factors influancing on this metabolism, the laboratory hyperurycemia criteria and the mode of hyperuricemia treatment are presented. The hyperuricemia and it's collaboration with the other coronary risk factors are analysed as an independent risk factors. Hyperuricemia is described as an increased concentration of uric acid in blood. The urate concentration is elevated when the upper level of arbitrary accepted value is exceeded. That corresponds to the mean value of urate concentration of particular sex and age plus two standard deviations. In most cases of epidemiologic investigations the upper normal range of concentration equals 6 mg/dl for women and 7 mg/dl for men. An increased level of uric acid leads to urate gout (diathesis urica). An increased level of urate in serum is connected with numerous cardiovascular risk factors such as: arterial hypertension, hyperglycemia, diabetes and male sex. But up today, hyperuricemia is not used as independent direct risk factor, so the reduction of uric acid is not obligatory recommended in guidelines for prevention of cardiovascular diseases and stroke.
Similar articles
-
[Is hyperuricemia a cardiovascular risk factor?].Wiad Lek. 2006;59(5-6):364-7. Wiad Lek. 2006. PMID: 17017483 Review. Polish.
-
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.Arthritis Rheum. 2008 Nov 15;59(11):1540-8. doi: 10.1002/art.24209. Arthritis Rheum. 2008. PMID: 18975369 Clinical Trial.
-
[Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].Nihon Rinsho. 2008 Apr;66(4):729-35. Nihon Rinsho. 2008. PMID: 18409523 Review. Japanese.
-
Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.J Rheumatol. 2009 Jun;36(6):1273-82. doi: 10.3899/jrheum.080814. Epub 2009 Mar 13. J Rheumatol. 2009. PMID: 19286847
-
Women with gout: efficacy and safety of urate-lowering with febuxostat and allopurinol.Arthritis Care Res (Hoboken). 2012 Feb;64(2):256-61. doi: 10.1002/acr.20680. Arthritis Care Res (Hoboken). 2012. PMID: 22052584 Clinical Trial.
Cited by
-
Lactobacillus reuteri TSR332 and Lactobacillus fermentum TSF331 stabilize serum uric acid levels and prevent hyperuricemia in rats.PeerJ. 2021 May 3;9:e11209. doi: 10.7717/peerj.11209. eCollection 2021. PeerJ. 2021. PMID: 33986988 Free PMC article.
-
Modified Chuanhu anti-gout mixture, a traditional Chinese medicine, protects against potassium oxonate-induced hyperuricemia and renal dysfunction in mice.J Int Med Res. 2019 May;47(5):1927-1935. doi: 10.1177/0300060519831182. Epub 2019 Mar 5. J Int Med Res. 2019. PMID: 30832523 Free PMC article.
-
Association between metabolic status and gut microbiome in obese populations.Microb Genom. 2021 Aug;7(8):000639. doi: 10.1099/mgen.0.000639. Microb Genom. 2021. PMID: 34356001 Free PMC article.
-
Gender, body mass index, and PPARγ polymorphism are good indicators in hyperuricemia prediction for Han Chinese.Genet Test Mol Biomarkers. 2013 Jan;17(1):40-6. doi: 10.1089/gtmb.2012.0231. Genet Test Mol Biomarkers. 2013. PMID: 23237621 Free PMC article.
-
First Report on Association of Hyperuricemia with Type 2 Diabetes in a Vietnamese Population.Int J Endocrinol. 2019 Sep 2;2019:5275071. doi: 10.1155/2019/5275071. eCollection 2019. Int J Endocrinol. 2019. PMID: 31565055 Free PMC article.